ืœื•ื ื’

Atreca Inc - It's time to load up. ๐Ÿง™

365
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.
-20%

If you want not to miss ideas like this one,๐ŸŽฏ subscribe and press a thumb up! ๐Ÿ‘ Have a question? Don't be shy to ask! ๐Ÿค“ Interested to study how to analyze charts, follow me!

ื›ืชื‘ ื•ื™ืชื•ืจ

ื”ืžื™ื“ืข ื•ื”ืคืจืกื•ืžื™ื ืื™ื ื ืืžื•ืจื™ื ืœื”ื™ื•ืช, ื•ืื™ื ื ืžื”ื•ื•ื™ื, ืขืฆื•ืช ืคื™ื ื ืกื™ื•ืช, ื”ืฉืงืขื•ืช, ืžืกื—ืจ ืื• ืกื•ื’ื™ื ืื—ืจื™ื ืฉืœ ืขืฆื•ืช ืื• ื”ืžืœืฆื•ืช ืฉืกื•ืคืงื• ืื• ืžืื•ืฉืจื™ื ืขืœ ื™ื“ื™ TradingView. ืงืจื ืขื•ื“ ื‘ืชื ืื™ื ื•ื”ื”ื’ื‘ืœื•ืช.